Admission serum magnesium level does not predict the hospital outcome of patients with acute myocardial infarction

Archives of Internal Medicine

Volumn 156, Issue 15, 1996, Pages 1701-1708

  Madias, John E ^a,b   Sheth, Ketan ^a,b   Choudry, Mubashar A ^a,b   Berger, David O ^a,b   Madias, Nicolaos E ^c  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b ELMHURST HOSPITAL CENTER   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIURETIC AGENT; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; HEPARIN; MAGNESIUM; NITRATE; POTASSIUM;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY CARE UNIT; EMERGENCY WARD; FEMALE; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITAL ADMISSION; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; FEMALE; HEART ARREST; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TACHYCARDIA;

EID: 0029823180     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.15.1701     Document Type: Article

References (51)

1. Woods, KL, Fletcher S, Roffe C, Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1992;339:1553-1558.
2. ISIS-4 (Fourth International Study of lnfarct Survival) Collaborative Group. ISIS-4: a randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet. 1995;345:669-685.
3. Abraham AS, Eylath V, Weinstein M, Czaczkes E. Serum magnesium levels in patients with acute myocardial infarction. N Engl J Med. 1977;296:862-863.
4. Dyckner T. Serum magnesium in acute myocardial infarction: relation to arrhythmias. Acta Med J Scand. 1980;207:59-66.
5. Rector WG, DeWood MA, Williams RV, Sullivan JF. Serum magnesium and copper levels in myocardial infarction. Am J Med Sci. 1981;281:25-29.
6. Rasmussen HS, Aurup P, Hojberg S, Jensen K, McNair P. Magnesium and acute myocardial infarction: transient hypomagnesemia not induced by renal magnesium loss in patients with acute myocardial infarction. Arch Intern Med. 1986;146:872-874.
7. Petersen B, Christiansen C, Transbol I. Blood minerals in cardiac emergencies. Dan Med Bull. 1978;25:116-118.
8. Zumkley H, Vetter H, Bertram HP, Tank B, Wirth W. Phasma zinc and magnesium alterations in acute myocardial infarction. Klin Wochenschr. 1980:58: 1143-1146.
9. Flink EB, Brink JE, Shane SR. Alterations of long-chain free fatty acid and magnesium concentrations in acute myocardial infarction. Arch Intern Med. 1981; 141:441-443.
10. Brown DF, McGandy RB, Gillie E, Doyle JT. Magneseium-lipid relations in health and in patients with myocardial infarction. Lancet. 1958;2:933-935.
11. Hyatt KH, Levy L, Nicharman M, et al. Relationship of serum magnesium levels to serum cholesterol and triglyceride levels and to myocardial infarction. Appl Spectroscopy. 1966;20:142-145.
12. EIIis VM, Walmsley RN. A comparison of plasma magnesium values in patients with acute myocardial infarction and patients with chest pain due to other causes. Med J Aust. 1988;148:14-16.
13. Lund B, Badskjaer J, Lund B, Sorensen OH. Vitamin D and ischemic heart disease. Horm Metab Res. 1978;10:553-556.
14. Speich M, Bousquet B, Nicolas G. Concentrations of magnesium, calcium, potassium, and sodium in human heart muscle after acute myocardial infarction. Clin Chem. 1980;26:1662-1665.
15. Gould L, Reddy CVR, Swamy CRN, Oh KC, Kirn SG. Decline of serum phosphorus in acute myocardial infarction. Angiology. 1979;30:219-222.
16. Bigg RPC, Chia R. Magnesium deficiency: role in arrhythmias complicating acute myocardial infarction? Med J Aust. 1981;1:346-348.
17. Salem M, Kasinski N, Andrei AM, et al. Hypomagnesemia is a frequent finding in the emergency department in patients with chest pain. Arch Intern Med. 1991;151:2185-2190.
18. Abraham AS, Rosenman O, Meshulam Z, Zion M, Eylath V. Serum, lymphocyte, and erythrocyte potassium, magnesium, and calcium concentrations and their relation to tachyarrhythmias in patients with acute myocardial infarction. Am J Med. 1986;81:983-988.
19. Cooperating Investigators From the MILIS Study Group. Electrocardiographic, enzymatic and scintigraphic criteria of acute myocardial infarction as determined from study of 726 patients (MILIS study). Am J Cardiol. 1985;55:1463-1468.
20. Madias JE, Chahine RA, Gorlin R, Blacklow DJ. A comparison of transmural and nontransmural acute myocardial infarction. Circulation. 1974:49:498-507.
21. Killip T III, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol. 1967:20:457-464.
22. Tietz NW. Textbook of Clinical Chemistry 1986. Philadelphia, Pa: WB Saunders Co; 1986:974.
23. Rentrop KP, Feit F, Sherman W, et al. Late thrombolytic therapy preserves left ventricular function in patients with collateralized total coronary occlusion: primary end point findings of the second Mount Sinai-New York University reperfusion trial. J Am Coll Cardiol. 1989;14:58-64.
24. Norusis M. The SPSS Guide to Data Analysis for SPSS/SPC+. 2nd ed. Chicago, III: SPSS lnc; 1991:88, 219, 245, 268, 331.
25. Rasmussen HS, McNair P, Noregard P, Backer V, Lindeneg O, Balslev S. Intravenous magnesium in acute myocardial infarction. Lancet. 1986;1:234-236.
26. Flink EB. Magnesium deficiency: etiology and clinical spectrum. Acta Med Scand Suppl. 1981;647:125-137.
27. Cox JR Jr, Roberts R, Ambos HD, Oliver GC, Sobel BE. Relations between enzymatically estimated myocardial infarct size and early ventricular dysrhythmia. Circulation. 1976;53(suppl l):l-150-l-155.
28. Meltzer LE, Cohen HE. The incidence of arrhythmias associated with acute myocardial infarction. In: Meltzer LE, Dunning AJ, eds. Textbook of Coronary Care. Philadelphia, Pa: Charles Press; 1972:107-133.
29. Nath K, Sikka K, Sur B. Serum magnesium in clinical and experimental myocardial infarction, lnd J Med Res. 1969;57:317-323.
30. National Heart Attack Alert Program Coordinating Committee, 60 Minutes to Treatment Working Group. Emergency department: rapid identification and treatment of patients with acute myocardial infarction. Ann Emerg Med. 1994;23: 311-329.
31. Ebel H, Gunther T. Role of magnesium in cardiac disease. J Clin Chem Clin Biochem. 1983;21:249-265.
32. Rayssiguier Y. Hypomagnesemia resulting from adrenaline infusion in ewes: its relation to lipolysis. Horm Metab Res. 1977;9:309-314.
33. Elliott DA, Rizack MA. Epinephrine and adrenocorticatropic hormone stimulated magnesium accumulation in adipocytes and their plasma membranes. J Biol Chem. 1974:249:3985-3990.
34. Bremme K, Eneroth P, Nordstrom L, Nilsson B. Effects of infusion of the beta adrenoceptor agonist terbutaline on serum magnesium in pregnant women. Magnesium. 1986;5:85-94.
35. Whyte K, Addis GJ, Whitesmith R, Reid JL. Adrenergic control of plasma magnesium in man. Clin Sci. 1967;72:135-138.
36. 2-receptor stimulation by circulating epinephrine. N Engl J Med. 1983;309:1414-1419.
37. Hatfner CA, Kendall MJ. Metabolic effects of beta 2-agonists. J Clin Pharm Ther. 1992;17:155-164.
38. Vetter NJ, Adams W, Strange RC, Oliver MF. Initial metabolic and hormonal response to acute myocardial infarction. Lancet. 1974;1:284-289.
39. Cohen L, Laor A, Kitzes R. Serum magnesium inpropranolol-treated patients with acute myocardial infarction. Magnesium. 1984;3:138-144.
40. Abraham AS, Rosenmann D, Kramer M, et al. Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction. Arch Intern Med. 1987;147: 753-755.
41. Smith LF, Heagerty AM, Bing RF, Barnett DB. Intravenus infusion of magnesium sulfate after acute myocardial infarction: effects on arrhythmias and mortality. Int J Cardiol. 1986;12:175-180.
42. Rasmussen HS, Suenson M, McNair P, Norregard P, Balslev S. Magnesium infusion reduces the incidence of arrhythmias in acute myocardial infarction: a double-blind placebo-controlled study. Clin Cardiol. 1987;10:351-356.
43. Tzivoni D, Karen A, Cohen AM, et al. Magnesium therapy for torsade de pointes. Am J Cardiol. 1984;53:528-530.
44. lseri LT, Fairshter RD, Hardernan JL, Brodsky MA. Magnesium and potassium therapy in multifocal atrial tachycardia. Am Heart J. 1985;110:789-794.
45. lseri LT. Role of magnesium in cardiac tachyarrhythmias. Am J Cardiol. 1990; 65:47K-50K.
46. Kugiyama K, Yasue H, Okumura K, et al. Supression of exercise-induced angina by magnesium sulfate in patients with variant angina. J Am Coll Cardiol. 1988;12:1177-1783.
47. Miyagi H, Yasue H, Okumura K. Effect of magnesium on anginal attack induced by hyperventilation in patients with variant angina. Circulation. 1989; 79:597-602.
48. Abraham AS, Shaul R, Shimonovitz S, Eylath V, Weinstein M. Serum magnesium levels in acute medical and surgical conditions, Biochem Med. 1980;24:21-26.
49. Wong ET, Rude RK, Singer FR, Shaw ST. A high prevalence of hypomagnesemia and hypermagnesemia in hospitalized patients. Am J Clin Pathol. 1982; 79:348-352.
50. Ryzen E, Wagers PW, Singer FR, Rude RK. Magnesium deficiency in a medical ICU population. Crit Care Med. 1985;13:19-21.
51. Chernow B, Bamberger S, Stoiko M, et al. Hypomagnesemia in patients in post-operative intensive care. Chest. 1989;95:391-397.